Infusion related reaction: FDA reporting patterns
65,185 FDA FAERS reports mention Infusion related reaction. 51,530 reports have a serious outcome flag.
Medicines named as suspect
- Infliximab: 19,595 reports
- Rituximab: 13,461 reports
- Tocilizumab: 8,902 reports
- Methotrexate: 7,801 reports
- Adalimumab: 7,728 reports
- Etanercept: 7,363 reports
- Abatacept: 7,296 reports
- Prednisone: 7,028 reports
- Leflunomide: 6,692 reports
- Cetirizine: 6,457 reports
- Diclofenac: 6,423 reports
- Hydroxychloroquine: 6,413 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.